Evidence map›Paper›PMID 40335942›Full record

ArticleBMC plant biology2025

Biosynthesized sulfur nanoparticles: a novel strategy to enhance antioxidant secondary metabolites in Lotus arabicus L. callus cultures.

Sherien E Sobhy, Asmaa M Khalifa, Elsayed E Hafez, Doaa E Elsherif

Abstract read
In one paragraph

Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sherien E SobhyPlant Protection and Bimolecular Diagnosis Department, Arid Lands Cultivation Research Institute, City of Scientific Research and Technological Applications, New Borg El-Arab, 21934, Egypt.
Asmaa M KhalifaBotany and Microbiology Department, Faculty of Science, Al-Azhar University (Girls Branch), 11754 , Nasr City, Cairo, Egypt.
Elsayed E HafezPlant Protection and Bimolecular Diagnosis Department, Arid Lands Cultivation Research Institute, City of Scientific Research and Technological Applications, New Borg El-Arab, 21934, Egypt.
Doaa E ElsherifBotany Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt. doaa.elsherif@science.tanta.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSecondary metabolites are distinct compounds with significant medicinal value, yet their production and chemical synthesis present considerable challenges. This necessitates the development of innovative strategies to improve their yield. This study investigated the potential of biosynthesized sulfur nanoparticles (SNPs) as an eco-friendly elicitor to enhance the synthesis of antioxidant secondary metabolites in Lotus arabicus L. callus cultures.

resultsAfter seven weeks, induced calli of L. arabicus L were transferred to MS media supplemented with SNPs at different concentrations (0, 25, 50, 100, and 200 mg/l). The results indicated that SNPs (100 mg/l) induced significantly higher profiles for biomass and secondary metabolite compared to the control treatments. Enzyme activities related to secondary metabolite biosynthesis, specifically phenylalanine ammonia lyase (PAL) and polyphenol oxidase (PPO) were enhanced in a dose-dependent manner, with the greatest increases observed at 100 mg/l SNPs. The SNPs also modulated oxidative stress markers (MDA and H

conclusionOverall, the supplementation of SNPs in the culture media of L. arabicus L callus positively influenced secondary metabolite production at the molecular and physiological levels, increasing its potential for medicinal use.

Indexed as

AntioxidantsLotusNanoparticlesSecondary MetabolismSulfurOxidative StressPhenylalanine Ammonia-LyaseAntioxidantsPhenylalanine Ammonia-LyaseSulfurAntioxidantCallus cultureElicitationGene expressionLotus arabicus L.PhenolicSulfur nanoparticles

Identifiers

PMID40335942
PMCPMC12057069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.